Skip to main content
. 2021 Jun 12;7:292–323. doi: 10.1016/j.bioactmat.2021.05.038

Scheme 1.

Scheme 1

Nanocarrier-based systems for delivery of oligonucleotides for molecular therapy of cancers. Abbreviations: ASO, Antisense oligonucleotides; miRNA, microRNA; mRNA, messenger RNA; siRNA, small interfering RNA; RISC, RNA-induced silencing complex; TLR9, Toll-like receptors 9.